BioMarin Pharmaceutical Inc.
BMRN
$58.58
$0.510.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.43B | 1.27B | 1.14B | 930.44M | 1.22B |
| Total Receivables | 855.86M | 739.18M | 660.54M | 777.55M | 691.23M |
| Inventory | 1.34B | 1.27B | 1.23B | 1.18B | 1.18B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 177.18M | 181.55M | 201.53M | 169.26M | 160.43M |
| Total Current Assets | 3.81B | 3.47B | 3.23B | 3.06B | 3.26B |
|
|
|||||
| Total Current Assets | 3.81B | 3.47B | 3.23B | 3.06B | 3.26B |
| Net Property, Plant & Equipment | 1.03B | 1.03B | 1.08B | 1.05B | 1.05B |
| Long-term Investments | 196.20M | 196.20M | 196.20M | 196.20M | 196.20M |
| Goodwill | 196.20M | 196.20M | 196.20M | 196.20M | 196.20M |
| Total Other Intangibles | 239.62M | 247.35M | 327.38M | 260.92M | 265.53M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.68B | 1.70B | 1.63B | 1.72B | 1.73B |
| Total Assets | 7.46B | 7.15B | 6.99B | 6.85B | 7.07B |
|
|
|||||
| Total Accounts Payable | 310.80M | 293.75M | 235.40M | 312.32M | 257.41M |
| Total Accrued Expenses | 290.59M | 276.67M | 331.27M | 349.50M | 268.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.70M | 6.31M | 7.57M | 8.06M | 505.53M |
| Total Finance Division Other Current Liabilities | 75.16M | 51.48M | 32.74M | 45.78M | 35.56M |
| Total Other Current Liabilities | 75.16M | 51.48M | 32.74M | 45.78M | 35.56M |
| Total Current Liabilities | 684.25M | 628.21M | 606.99M | 715.66M | 1.07B |
|
|
|||||
| Total Current Liabilities | 684.25M | 628.21M | 606.99M | 715.66M | 1.07B |
| Long-Term Debt | 596.16M | 595.65M | 595.14M | 594.63M | 594.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 31.26M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 148.82M | 129.69M | 97.57M | 127.51M | 119.37M |
| Total Liabilities | 1.43B | 1.35B | 1.33B | 1.44B | 1.78B |
|
|
|||||
| Common Stock & APIC | 5.85B | 5.79B | 5.80B | 5.74B | 5.70B |
| Retained Earnings | 231.52M | -9.01M | -194.70M | -319.64M | -425.72M |
| Treasury Stock & Other | -56.24M | 7.97M | 50.43M | -7.07M | 15.13M |
| Total Common Equity | 6.03B | 5.79B | 5.66B | 5.41B | 5.29B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.03B | 5.79B | 5.66B | 5.41B | 5.29B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.03B | 5.79B | 5.66B | 5.41B | 5.29B |
|
|
|||||